Laboratory Medicine ›› 2023, Vol. 38 ›› Issue (4): 357-361.DOI: 10.3969/j.issn.1673-8640.2023.04.011
Previous Articles Next Articles
FANG Yongmei, ZHANG Yan, XU Xueying, ZHONG Feng()
Received:
2021-12-17
Revised:
2022-06-18
Online:
2023-04-28
Published:
2023-06-21
CLC Number:
FANG Yongmei, ZHANG Yan, XU Xueying, ZHONG Feng. Correlation of Staphylococcus aureus drug resistance with drug resistance genes and virulence genes[J]. Laboratory Medicine, 2023, 38(4): 357-361.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2023.04.011
基因名称 | 引物序列(5'~3') | 产物大小/bp |
---|---|---|
mecA | F:ACGAGTAGATGCTCAATATAA | 293 |
R:CTTAGTTCTTTAGCGATTGC | ||
mecC | F:GAAAAAAAGGCTTAGAACGCCTC | 138 |
R:GAGATCTTTTCCGTTTTCAGC | ||
SEA | F:GGTTATCAATGTGCGGGTGG | 232 |
R:CGGCACTTTTTTCTCTTCGG | ||
ermA | F:GTTCAAGAACAATCACAGAG | 533 |
R:GGATCAGGAAAAGGACATTTTAC |
基因名称 | 引物序列(5'~3') | 产物大小/bp |
---|---|---|
mecA | F:ACGAGTAGATGCTCAATATAA | 293 |
R:CTTAGTTCTTTAGCGATTGC | ||
mecC | F:GAAAAAAAGGCTTAGAACGCCTC | 138 |
R:GAGATCTTTTCCGTTTTCAGC | ||
SEA | F:GGTTATCAATGTGCGGGTGG | 232 |
R:CGGCACTTTTTTCTCTTCGG | ||
ermA | F:GTTCAAGAACAATCACAGAG | 533 |
R:GGATCAGGAAAAGGACATTTTAC |
抗菌药物 | MRSA/% | MSSA/% | χ2值 | P值 |
---|---|---|---|---|
苯唑西林 | 100.00 | 0 | 220.000 | 0.000 |
青霉素 | 100.00 | 86.36 | 16.098 | 0.000 |
红霉素 | 77.27 | 47.27 | 21.069 | 0.000 |
克林霉素 | 64.55 | 35.45 | 18.618 | 0.000 |
利福平 | 17.27 | 0 | 20.796 | 0.000 |
氯霉素 | 33.66 | 12.73 | 13.503 | 0.000 |
四环素 | 53.66 | 7.27 | 55.821 | 0.000 |
莫西沙星 | 55.45 | 10.91 | 49.224 | 0.000 |
万古霉素 | 0 | 0 | ||
利奈唑胺 | 0 | 0 | ||
环丙沙星 | 57.29 | 24.55 | 24.369 | 0.000 |
左氧氟沙星 | 67.27 | 30.91 | 29.101 | 0.000 |
复方磺胺甲噁唑 | 13.64 | 2.73 | 8.713 | 0.003 |
奎奴普丁-达福普丁 | 0 | 0 | ||
庆大霉素 | 32.73 | 6.36 | 24.310 | 0.000 |
抗菌药物 | MRSA/% | MSSA/% | χ2值 | P值 |
---|---|---|---|---|
苯唑西林 | 100.00 | 0 | 220.000 | 0.000 |
青霉素 | 100.00 | 86.36 | 16.098 | 0.000 |
红霉素 | 77.27 | 47.27 | 21.069 | 0.000 |
克林霉素 | 64.55 | 35.45 | 18.618 | 0.000 |
利福平 | 17.27 | 0 | 20.796 | 0.000 |
氯霉素 | 33.66 | 12.73 | 13.503 | 0.000 |
四环素 | 53.66 | 7.27 | 55.821 | 0.000 |
莫西沙星 | 55.45 | 10.91 | 49.224 | 0.000 |
万古霉素 | 0 | 0 | ||
利奈唑胺 | 0 | 0 | ||
环丙沙星 | 57.29 | 24.55 | 24.369 | 0.000 |
左氧氟沙星 | 67.27 | 30.91 | 29.101 | 0.000 |
复方磺胺甲噁唑 | 13.64 | 2.73 | 8.713 | 0.003 |
奎奴普丁-达福普丁 | 0 | 0 | ||
庆大霉素 | 32.73 | 6.36 | 24.310 | 0.000 |
基因名称 | MRSA(110株) | MSSA(110株) | χ2值 | P值 | ||
---|---|---|---|---|---|---|
阳性/[株(%)] | 阴性/[株(%)] | 阳性/[株(%)] | 阴性/[株(%)] | |||
mecA | 110(100.00) | 0(0) | 5(4.55) | 105(95.45) | 76.364 | 0.000 |
ermA | 65(59.09) | 45(40.91) | 8(7.27) | 102(92.73) | 66.609 | 0.000 |
SEA | 93(84.55) | 17(15.45) | 17(15.45) | 93(84.55) | 105.018 | 0.000 |
mecC | 39(35.45) | 71(64.55) | 12(10.91) | 98(89.09) | 18.608 | 0.000 |
基因名称 | MRSA(110株) | MSSA(110株) | χ2值 | P值 | ||
---|---|---|---|---|---|---|
阳性/[株(%)] | 阴性/[株(%)] | 阳性/[株(%)] | 阴性/[株(%)] | |||
mecA | 110(100.00) | 0(0) | 5(4.55) | 105(95.45) | 76.364 | 0.000 |
ermA | 65(59.09) | 45(40.91) | 8(7.27) | 102(92.73) | 66.609 | 0.000 |
SEA | 93(84.55) | 17(15.45) | 17(15.45) | 93(84.55) | 105.018 | 0.000 |
mecC | 39(35.45) | 71(64.55) | 12(10.91) | 98(89.09) | 18.608 | 0.000 |
抗菌药物 | mecA | mecC | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
阳性(115株)/% | 阴性(105株)/% | χ2值 | P值 | 阳性(51株)/% | 阴性(169株)/% | χ2值 | P值 | ||||
苯唑西林 | 95.65 | 0 | 200.870 | 0.000 | 76.47 | 42.01 | 18.608 | 0.000 | |||
青霉素 | 100.00 | 85.71 | 17.631 | 0.000 | 96.08 | 92.31 | 0.877 | 0.349 | |||
红霉素 | 75.65 | 49.52 | 16.108 | 0.000 | 74.51 | 58.58 | 4.232 | 0.040 | |||
克林霉素 | 64.35 | 34.29 | 19.312 | 0.000 | 58.82 | 47.34 | 2.068 | 0.150 | |||
利福平 | 16.52 | 0 | 18.988 | 0.000 | 23.53 | 4.14 | 18.662 | 0.000 | |||
氯霉素 | 33.04 | 12.38 | 13.159 | 0.000 | 31.37 | 26.63 | 0.004 | 0.000 | |||
四环素 | 53.91 | 4.76 | 62.605 | 0.000 | 47.06 | 25.44 | 8.642 | 0.003 | |||
莫西沙星 | 44.34 | 20.95 | 13.550 | 0.000 | 58.82 | 25.44 | 19.688 | 0.000 | |||
万古霉素 | 0 | 0 | 0 | 0 | |||||||
利奈唑胺 | 0 | 0 | 0 | 0 | |||||||
环丙沙星 | 56.52 | 23.81 | 27.476 | 0.000 | 70.59 | 31.95 | 24.192 | 0.000 | |||
左氧氟沙星 | 67.83 | 28.57 | 33.842 | 0.000 | 62.75 | 44.97 | 4.953 | 0.026 | |||
复方磺胺甲噁唑 | 13.91 | 1.90 | 9.551 | 0.002 | 13.73 | 7.10 | 2.179 | 0.140 | |||
奎奴普丁-达福普丁 | 0 | 0 | 0 | 0 | |||||||
庆大霉素 | 33.04 | 4.76 | 27.917 | 0.000 | 27.45 | 17.16 | 2.639 | 0.104 | |||
抗菌药物 | SEA | ermA | |||||||||
阳性(110株)/% | 阴性(110株)/% | χ2值 | P值 | 阳性(73株)/% | 阴性(147株)/% | χ2值 | P值 | ||||
苯唑西林 | 84.55 | 15.45 | 105.018 | 0.000 | 89.04 | 30.61 | 90.818 | 0.000 | |||
青霉素 | 100.00 | 86.36 | 5.634 | 0.018 | 98.63 | 90.47 | 5.105 | 0.024 | |||
红霉素 | 80.91 | 43.64 | 32.523 | 0.000 | 80.82 | 53.06 | 16.000 | 0.000 | |||
克林霉素 | 67.27 | 32.73 | 26.255 | 0.000 | 43.84 | 53.06 | 1.661 | 0.198 | |||
利福平 | 15.45 | 1.82 | 12.962 | 0.000 | 13.69 | 6.12 | 3.548 | 0.040 | |||
氯霉素 | 30.91 | 15.45 | 7.377 | 0.007 | 44.66 | 22.45 | 0.134 | 0.015 | |||
四环素 | 48.18 | 12.73 | 32.643 | 0.000 | 45.21 | 23.13 | 11.224 | 0.001 | |||
莫西沙星 | 42.73 | 23.64 | 12.608 | 0.000 | 52.05 | 23.81 | 3.388 | 0.046 | |||
万古霉素 | 0 | 0 | 0 | 0 | |||||||
利奈唑胺 | 0 | 0 | 0 | 0 | |||||||
环丙沙星 | 50.91 | 30.91 | 13.465 | 0.000 | 47.95 | 37.41 | 2.237 | 0.135 | |||
左氧氟沙星 | 62.73 | 35.45 | 16.369 | 0.000 | 58.90 | 44.22 | 4.210 | 0.040 | |||
复方磺胺甲噁唑 | 10.91 | 5.45 | 2.178 | 0.140 | 12.33 | 6.12 | 2.501 | 0.114 | |||
奎奴普丁-达福普丁 | 0 | 0 | 0 | 0 | |||||||
庆大霉素 | 28.18 | 10.91 | 10.435 | 0.001 | 54.79 | 2.04 | 86.323 | 0.000 |
抗菌药物 | mecA | mecC | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
阳性(115株)/% | 阴性(105株)/% | χ2值 | P值 | 阳性(51株)/% | 阴性(169株)/% | χ2值 | P值 | ||||
苯唑西林 | 95.65 | 0 | 200.870 | 0.000 | 76.47 | 42.01 | 18.608 | 0.000 | |||
青霉素 | 100.00 | 85.71 | 17.631 | 0.000 | 96.08 | 92.31 | 0.877 | 0.349 | |||
红霉素 | 75.65 | 49.52 | 16.108 | 0.000 | 74.51 | 58.58 | 4.232 | 0.040 | |||
克林霉素 | 64.35 | 34.29 | 19.312 | 0.000 | 58.82 | 47.34 | 2.068 | 0.150 | |||
利福平 | 16.52 | 0 | 18.988 | 0.000 | 23.53 | 4.14 | 18.662 | 0.000 | |||
氯霉素 | 33.04 | 12.38 | 13.159 | 0.000 | 31.37 | 26.63 | 0.004 | 0.000 | |||
四环素 | 53.91 | 4.76 | 62.605 | 0.000 | 47.06 | 25.44 | 8.642 | 0.003 | |||
莫西沙星 | 44.34 | 20.95 | 13.550 | 0.000 | 58.82 | 25.44 | 19.688 | 0.000 | |||
万古霉素 | 0 | 0 | 0 | 0 | |||||||
利奈唑胺 | 0 | 0 | 0 | 0 | |||||||
环丙沙星 | 56.52 | 23.81 | 27.476 | 0.000 | 70.59 | 31.95 | 24.192 | 0.000 | |||
左氧氟沙星 | 67.83 | 28.57 | 33.842 | 0.000 | 62.75 | 44.97 | 4.953 | 0.026 | |||
复方磺胺甲噁唑 | 13.91 | 1.90 | 9.551 | 0.002 | 13.73 | 7.10 | 2.179 | 0.140 | |||
奎奴普丁-达福普丁 | 0 | 0 | 0 | 0 | |||||||
庆大霉素 | 33.04 | 4.76 | 27.917 | 0.000 | 27.45 | 17.16 | 2.639 | 0.104 | |||
抗菌药物 | SEA | ermA | |||||||||
阳性(110株)/% | 阴性(110株)/% | χ2值 | P值 | 阳性(73株)/% | 阴性(147株)/% | χ2值 | P值 | ||||
苯唑西林 | 84.55 | 15.45 | 105.018 | 0.000 | 89.04 | 30.61 | 90.818 | 0.000 | |||
青霉素 | 100.00 | 86.36 | 5.634 | 0.018 | 98.63 | 90.47 | 5.105 | 0.024 | |||
红霉素 | 80.91 | 43.64 | 32.523 | 0.000 | 80.82 | 53.06 | 16.000 | 0.000 | |||
克林霉素 | 67.27 | 32.73 | 26.255 | 0.000 | 43.84 | 53.06 | 1.661 | 0.198 | |||
利福平 | 15.45 | 1.82 | 12.962 | 0.000 | 13.69 | 6.12 | 3.548 | 0.040 | |||
氯霉素 | 30.91 | 15.45 | 7.377 | 0.007 | 44.66 | 22.45 | 0.134 | 0.015 | |||
四环素 | 48.18 | 12.73 | 32.643 | 0.000 | 45.21 | 23.13 | 11.224 | 0.001 | |||
莫西沙星 | 42.73 | 23.64 | 12.608 | 0.000 | 52.05 | 23.81 | 3.388 | 0.046 | |||
万古霉素 | 0 | 0 | 0 | 0 | |||||||
利奈唑胺 | 0 | 0 | 0 | 0 | |||||||
环丙沙星 | 50.91 | 30.91 | 13.465 | 0.000 | 47.95 | 37.41 | 2.237 | 0.135 | |||
左氧氟沙星 | 62.73 | 35.45 | 16.369 | 0.000 | 58.90 | 44.22 | 4.210 | 0.040 | |||
复方磺胺甲噁唑 | 10.91 | 5.45 | 2.178 | 0.140 | 12.33 | 6.12 | 2.501 | 0.114 | |||
奎奴普丁-达福普丁 | 0 | 0 | 0 | 0 | |||||||
庆大霉素 | 28.18 | 10.91 | 10.435 | 0.001 | 54.79 | 2.04 | 86.323 | 0.000 |
1. | Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty-fifth informational supplement[S]. M100-S25,CLSI, 2015. |
2. |
WALTERS M S, EGGERS P, ALBRECHT V, et al. Vancomycin-resistant Staphylococcus aureus-Delaware,2015[J]. MMWR Morb Mortal Wkly Rep, 2015, 64(37):1056.
DOI URL |
3. |
HU F, GUO Y, YANG Y, et al. Resistance reported from China antimicrobial surveillance network(CHINET)in 2018[J]. Eur J Clin Microbiol Infect Dis, 2019, 38(12):2275-2281.
DOI |
4. |
ALZOMOR O, ALFAWAZ T, ALSHAHRANI D. Invasive community-acquired methicillin-resistant Staphylococcus aureus(CA-MRSA)infection in children:case series and literature review[J]. Int J Pediatr Adolesc Med, 2017, 4(3):119-123.
DOI URL |
5. |
胡付品, 郭燕, 朱德妹, 等. 2020年CHINET中国细菌耐药监测[J]. 中国感染与化疗杂志, 2021, 21(4):377-387.
DOI |
6. |
SURANA K, SAGRULE D, LANJEWAR S. Primary closure with suction drain of acute breast abscess after incision,drainage,and curettage[J]. Indian J Surg, 2020, 82:129-133.
DOI |
7. | 杨斌, 李华. 2016—2019年陕西省榆林市细菌耐药监测网成员单位金黄色葡萄球菌的临床分布与耐药性变迁[J]. 现代检验医学杂志, 2021, 36(1):81-84. |
8. |
ASWANI V, NAJAR F, PANTRANGI M, et al. Virulence factor landscape of a Staphylococcus aureus sequence type 45 strain,MCRF184[J]. BMC Genomics, 2019, 20(1):123.
DOI |
9. | 林晓晖, 麦惠香, 简梦华, 等. 梅里埃VTIEK MS质谱仪在甲氧西林耐药及敏感的金黄色葡萄球菌快速鉴定的应用研究[J]. 现代检验医学杂志, 2020, 35(5):121-123. |
10. |
BOJER M S, FREES D, INGMER H. SosA in Staphylococci:an addition to the paradigm of membrane-localized,SOS-induced cell division inhibition in bacteria[J]. Curr Genet, 2020, 66(3):495-499.
DOI |
11. |
ANTONANZAS F, LOZANO C, TORRES C. Economic features of antibiotic resistance:the case of methicillin-resistant Staphylococcus aureus[J]. Pharmacoeconomics, 2015, 33(4):285-325.
DOI URL |
12. |
PARK S Y, SON J S, OH I H, et al. Clinical impact of methicillin-resistant Staphylococcus aureus bacteremia based on propensity scores[J]. Infection, 2011, 39(2):141-147.
DOI URL |
13. | 刘柔杉, 王俊瑞. 苯唑西林敏感耐甲氧西林金黄色葡萄球菌(OS-MRSA)研究进展[J]. 中国抗生素杂志, 2021, 46(8):736-742. |
14. |
SHRIEF R, El KHOLY R M, RIZK M A, et al. Prevalence of tetracycline resistant genes in Staphylococcus aureusisolates from surgical site infections egypt[J]. Biosci Biotech Res Asia, 2019, 16(2):221-228.
DOI URL |
[1] | WANG Chao, ZHAO Yu. Research progress on formation mechanism and eradication strategy of bacterial persisters [J]. Laboratory Medicine, 2023, 38(8): 790-795. |
[2] | ZHU Yurong, ZHANG Dan, HE Yaxing, LI Jingjing, HUANG Jing, LI Ting, LIU Peng, LIU Ronghua. Classification and epidemiology characteristics of Klebsiella pneumoniae isolated from clinic [J]. Laboratory Medicine, 2023, 38(5): 435-440. |
[3] | WANG Jiawei, ZHU Weinan, CHEN Yingying, JI Ping, WANG Ying. Clinical characteristics,molecular typing and drug resistance genes of carbapenem-resistant Klebsiella pneumoniae isolated from blood culturing [J]. Laboratory Medicine, 2023, 38(4): 362-367. |
[4] | REN Yanfei, ZHANG Min, YANG Tao, LI Rongkai, LIANG Xin. Analysis of pathogenic epidemiology of patients with lower respiratory tract infection in respiratory intensive care unit [J]. Laboratory Medicine, 2023, 38(2): 157-162. |
[5] | DENG Chen, DAI Jiaze, QIU Lihong, SHEN Weiting, CAI Mufa, LUO Wenying. Molecular epidemic characteristics of hypervirulent Klebsiella pneumoniae in Zhanjiang [J]. Laboratory Medicine, 2023, 38(11): 1026-1031. |
[6] | RU Haohao, CHEN Lianyong, YANG Xing, CHEN Tao, YAN Shuangqun, XU Lin. Analysis of rifampicin resistance in Mycobacterium tuberculosis determined by Xpert MTB/RIF and phenotypic drug susceptibility test [J]. Laboratory Medicine, 2023, 38(11): 1032-1035. |
[7] | WANG Su, DING Li, JIANG Wenrong, MIAO Yingxin, ZHANG Yanmei, ZHAO Hu. Research progress on drug resistance and treatment strategies of hypervirulent Klebsiella pneumoniae [J]. Laboratory Medicine, 2023, 38(1): 81-86. |
[8] | HAO Jiahui, YANG Zehua. Research progress of bacterial integron determination methods [J]. Laboratory Medicine, 2022, 37(9): 887-891. |
[9] | LI Hua, WANG Weiliang, XIE Bei, YANG Yu, MENG Fanrong, WANG Nan, LIU Zhihui, ZHANG Yanbin. Feasibility of the determination of heterogeneous drug resistance to rifampicin in Mycobacterium tuberculosis by flow cytometry [J]. Laboratory Medicine, 2022, 37(6): 577-582. |
[10] | TANG Jin, PAN Yunqi, YANG Yumei, WU Qiong, WANG Jianqiang, LI Yungai, DI Jianzhong. Research progress of methicillin-resistant Staphylococcus aureus screening and decolonization to reduce surgical site infection [J]. Laboratory Medicine, 2022, 37(5): 489-492. |
[11] | SUN Xiaodan, LIU Yiwen, HE Yiqing, DU Yan, ZHANG Guoliang, GAO Feng, YANG Cuixia. Research progress on the role of estrogen receptor in osteosarcoma [J]. Laboratory Medicine, 2022, 37(4): 313-318. |
[12] | WANG Jianying, WANG Shanshan, ZHU Jun, HUANG Xiaochun, WAN Yuxiang, LIU Yun. Distribution and drug resistance of respiratory infection pathogens in patients with lung cancer after chemotherapy [J]. Laboratory Medicine, 2022, 37(4): 356-359. |
[13] | PAN Yunqi, LI Yungai, WANG Jianqiang, WU Qiong, TANG Jin. Analysis of molecular typing,virulence genes and antibiotic susceptibility of uropathogenic Escherichia coli in patients with recurrent urinary tract infection [J]. Laboratory Medicine, 2022, 37(2): 141-145. |
[14] | SUN Ying, LI Yi, YAN Wenjuan, JING Nan, MA Bing. Analysis of drug resistance of rare CRE and clinical application of carbapenem screening test in Henan [J]. Laboratory Medicine, 2022, 37(2): 146-149. |
[15] | KANG Yi, ZHU Hong, SHEN Han, ZHOU Wanqing. Virulence gene analysis of Enterococcus isolated from clinical blood and urine samples [J]. Laboratory Medicine, 2022, 37(11): 1030-1033. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||